About Laurus Bio
Laurus Bio is a company based in Bengaluru (India) founded in 2005 by Rajesh Krishnamurthy was acquired by Laurus Labs in September 2023.. Laurus Bio has raised $18.89 million across 1 funding round from investors including Laurus Labs, Eight Roads Ventures and F-Prime Capital. The company has 347 employees as of April 03, 2024. Laurus Bio offers products and services including Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO. Laurus Bio operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Bengaluru, India
- Employees 347 as on 03 Apr, 2024
- Founders Rajesh Krishnamurthy
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Laurus Bio Private Limited
- Date of Incorporation 14 Jul, 2005
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$3.56 M (USD)-4.42as on Mar 31, 2017
-
Net Profit
$-902.1 K (USD)-8.21as on Mar 31, 2017
-
EBITDA
$-388.42 K (USD)-6.32as on Mar 31, 2017
-
Total Equity Funding
$18.89 M (USD)
in 1 rounds
-
Latest Funding Round
$18.89 M (USD), Series B
Dec 06, 2024
-
Investors
Laurus Labs
& 2 more
-
Employee Count
347
as on Apr 03, 2024
-
Acquired by
Laurus Labs
(Sep 11, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Laurus Bio
Laurus Bio offers a comprehensive portfolio of products and services, including Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Proteins and growth factors for safe medicines and sustainable food applications.
Services for strain engineering and fermentation scale-up in biopharma.
Unlock access to complete
Unlock access to complete
Funding Insights of Laurus Bio
Laurus Bio has successfully raised a total of $18.89M through 1 strategic funding round. The most recent funding activity was a Series B round of $18.89 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $18.9M
-
First Round
First Round
(06 Dec 2024)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series B - Laurus Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Laurus Bio
Laurus Bio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Laurus Labs, Eight Roads Ventures and F-Prime Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Pharmaceutical and biotechnology company
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Laurus Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Laurus Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Laurus Bio Comparisons
Competitors of Laurus Bio
Laurus Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Laurus Bio
Frequently Asked Questions about Laurus Bio
When was Laurus Bio founded?
Laurus Bio was founded in 2005 and raised its 1st funding round 19 years after it was founded.
Where is Laurus Bio located?
Laurus Bio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Laurus Bio?
Rajesh Krishnamurthy is the current CEO of Laurus Bio. They have also founded this company.
Is Laurus Bio a funded company?
Laurus Bio is a funded company, having raised a total of $18.89M across 1 funding round to date. The company's 1st funding round was a Series B of $18.89M, raised on Dec 06, 2024.
How many employees does Laurus Bio have?
As of Apr 03, 2024, the latest employee count at Laurus Bio is 347.
What is the annual revenue of Laurus Bio?
Annual revenue of Laurus Bio is $3.56M as on Mar 31, 2017.
What does Laurus Bio do?
Laurus Bio was founded in 2005 in Bengaluru, India, as an integrated biomanufacturing organization. Precision fermentation is utilized to engineer microbes for producing animal-free proteins and growth factors. Services extend to the biopharma, food, and regenerative medicine sectors, including clone development, strain engineering, and large-scale manufacturing under cGMP standards. Operations support cultured meat, cell culture media, and vaccine production across various markets.
Who are the top competitors of Laurus Bio?
Laurus Bio's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Laurus Bio offer?
Laurus Bio offers Animal-Free Recombinant Proteins and Microbial Precision Fermentation CDMO.
Who are Laurus Bio's investors?
Laurus Bio has 3 investors. Key investors include Laurus Labs, Eight Roads Ventures, and F-Prime Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.